Vor Biopharma Inc. (VOR) Misses Q3 EPS by 12150c

Vor Biopharma Inc. (NASDAQ: VOR) reported Q3 EPS of ($121.60), $121.50 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
• Westlake Corp adds dual listing on NYSE Texas exchange